VOLGA R1/0.3MG (Repaglinide (1mg) + Voglibose (0.3mg))

Volga R 1mg/0.3mg Tablet is a medicinal combination specifically designed for the management of type 2 diabetes mellitus. This formulation assists in regulating elevated blood sugar levels that may occur after meals. It is typically recommended when other similar treatments, combined with dietary modifications, fail to maintain blood sugar within normal ranges. The administration of Volga R should occur immediately following meals, and the prescribing physician will determine the appropriate dosage. It is crucial not to discontinue this medication without consulting your healthcare provider, as stopping abruptly could lead to an increase in blood sugar levels, which poses significant health risks such as kidney impairment or vision loss. In the event a dose is missed, it is advisable to wait until the next meal to take the medication rather than taking it between meals or doubling up on doses. This medication is intended to complement a comprehensive treatment strategy that includes a balanced diet, regular physical activity, and weight management, as directed by your healthcare professional. Monitoring blood glucose levels regularly is essential while on this medication. Additionally, it is important to inform your doctor about any existing kidney or liver issues, urinary tract infections, or if diuretics are being used. Pregnant or breastfeeding individuals should also seek medical advice prior to using this medication. Excessive alcohol consumption should be avoided, as it may heighten the likelihood of side effects.